LeMaitre Vascular
LMAT
155 hedge funds and large institutions have $470M invested in LeMaitre Vascular in 2019 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 60 increasing their positions, 39 reducing their positions, and 11 closing their positions.
20,767% more call options, than puts
Call options by funds: $626K | Put options by funds: $3K
155% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 11
54% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 39
32% more capital invested
Capital invested by funds: $355M → $470M (+$115M)
12% more funds holding
Funds holding: 139 → 155 (+16)
0.53% more ownership
Funds ownership: 76.77% → 77.3% (+0.53%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Copeland Capital Management
Conshohocken,
Pennsylvania
|
+$4.73M |
| 2 |
Millennium Management
New York
|
+$4.67M |
| 3 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$2.65M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$2.05M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$4.8M |
| 2 |
EIP
Epoch Investment Partners
New York
|
-$4.62M |
| 3 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$3M |
| 4 |
SCA
Summit Creek Advisors
Minneapolis,
Minnesota
|
-$2.84M |
| 5 |
RA
Royce & Associates
New York
|
-$2.02M |
LMAT Hedge Fund Activity: Q1 2019 in Review
155 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2019, worth a combined $470M — up 32% from $355M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new LMAT positions and 11 closed out — a net gain of 17 holders — while 60 added to existing stakes and 39 trimmed.
The largest buyer was Copeland Capital Management, adding an estimated $4.73M. The largest seller was Allianz Asset Management, cutting an estimated $4.8M.
- 155 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2019, up from 139 in Q4 2018.
- Funds reported $470M of LeMaitre Vascular stock for Q1 2019, up 32% quarter-over-quarter.
- 28 funds opened new LeMaitre Vascular positions in Q1 2019 and 11 closed out, a net change of +17 holders.
- The largest LeMaitre Vascular buyer in Q1 2019 was Copeland Capital Management, an estimated $4.73M added.
- The largest LeMaitre Vascular seller in Q1 2019 was Allianz Asset Management, an estimated $4.8M sold.
Based on aggregated 13F filings for Q1 2019.